Intuitive Surgical (NASDAQ:ISRG – Get Rating) had its target price cut by research analysts at Raymond James from $334.00 to $330.00 in a report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Raymond James’ price objective suggests a potential upside of 12.03% from the stock’s previous close.
A number of other analysts also recently weighed in on ISRG. Piper Sandler raised their price target on shares of Intuitive Surgical from $310.00 to $316.00 and gave the stock an “overweight” rating in a research report on Friday. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $370.00 to $325.00 and set a “buy” rating for the company in a research report on Friday, January 21st. StockNews.com began coverage on shares of Intuitive Surgical in a research report on Thursday, March 31st. They set a “hold” rating on the stock. Truist Financial initiated coverage on Intuitive Surgical in a report on Tuesday, April 12th. They issued a “buy” rating and a $360.00 price objective for the company. Finally, Royal Bank of Canada began coverage on Intuitive Surgical in a research note on Friday, March 25th. They set an “outperform” rating and a $340.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $334.02.
NASDAQ:ISRG opened at $294.57 on Friday. The firm has a 50-day moving average of $287.16 and a two-hundred day moving average of $315.27. The stock has a market cap of $105.81 billion, a P/E ratio of 63.12, a PEG ratio of 7.12 and a beta of 1.17. Intuitive Surgical has a 1-year low of $254.20 and a 1-year high of $369.69.
In other news, EVP Robert Desantis sold 1,410 shares of the firm’s stock in a transaction on Tuesday, January 25th. The stock was sold at an average price of $261.64, for a total transaction of $368,912.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 2,478 shares of the company’s stock in a transaction dated Wednesday, February 16th. The stock was sold at an average price of $289.00, for a total transaction of $716,142.00. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
A number of large investors have recently made changes to their positions in the stock. Hexagon Capital Partners LLC increased its position in shares of Intuitive Surgical by 200.0% during the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 46 shares during the period. Paragon Capital Management Ltd bought a new position in Intuitive Surgical during the fourth quarter valued at about $26,000. Hanseatic Management Services Inc. grew its holdings in Intuitive Surgical by 200.0% during the fourth quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 48 shares during the period. Standard Family Office LLC bought a new stake in Intuitive Surgical in the fourth quarter worth about $27,000. Finally, Wolff Wiese Magana LLC lifted its holdings in Intuitive Surgical by 1,000.0% in the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 70 shares during the last quarter. 44.03% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
- Should You Buy Carvana or AutoNation or Pass on Both?
- What Should Investors Take Away From Boston Beer’s Earnings?
- High-Yield Kinder Morgan Is Still A Buy
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.